Skip to main content

RXRX

Recursion Pharmaceuticals, Inc.

Company with tickers: RXRX

CIK
1601830
CUSIP
75629V104
Shares Outstanding
524,677,865
13F Activity (30d)
194 filings 190 filers

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2020-11-12 Amendment $245,896,677 $245,896,677
2020-09-15 New $235,506,731 $235,506,731
Showing 1–2 of 2 filings